Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GeneFormatics Inc.

This article was originally published in Start Up

Executive Summary

GeneFormatics means to develop computational tools that will help the pharmaceutical industry predict the three-dimensional structures and corresponding functions of proteins.

You may also be interested in...



Protein Structure/Function Determination

After 20 years and the efforts of thousands of researchers working on the problem structures have only been revealed for about 20,000 proteins out of 500,000 known protein sequences. When combined with the latest experimental and computational techniques, sequence and structural information provide some useful guidelines. Pharmaceutical companies are using it to sift from massive amounts of sequence information a more manageable number of biologically relevant targets; the undertaking is now known as structural genomics. Today this field is a hotbed of activity for new companies that offer improved X-ray crystallography techniques, nuclear magnetic resonance spectroscopy, annotated protein databases, computational algorithms, and combinations of all of the above.

Wound Solutions Ltd.

Wound Solutions Ltd. looks to the paradigm of patient self-care in diabetes to address the gaps in chronic wound care, where the feedback provided by blood glucose monitoring encourages changes in behavior. A small device that is placed under a compression bandage helps patients with venous leg ulcers comply with the steps they should be taking to support wound healing, in the process, collecting data that helps clinicians make informed therapy decisions.

Patient-Centric Devices Promise Cost-Efficient Advanced Wound Care

The treatment of chronic wounds is challenging, not only because of the underlying biology, but also because of more practical considerations: fragmentation in the care settings, the logistics of delivering products to patients, and the costs of chronic care. Next generation advanced wound care companies are engineering solutions to these problems.

Topics

Related Companies

Related Deals

UsernamePublicRestriction

Register

OM006664

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel